Envestnet Asset Management Inc. Acquires 16,698 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Envestnet Asset Management Inc. boosted its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH) by 5.6% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 316,489 shares of the company’s stock after purchasing an additional 16,698 shares during the quarter. Envestnet Asset Management Inc. owned approximately 2.08% of U.S. Physical Therapy worth $22,901,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in USPH. GAMMA Investing LLC boosted its position in shares of U.S. Physical Therapy by 27,856.8% during the 1st quarter. GAMMA Investing LLC now owns 12,301 shares of the company’s stock valued at $890,000 after acquiring an additional 12,257 shares during the last quarter. Lazard Asset Management LLC bought a new position in shares of U.S. Physical Therapy during the 4th quarter valued at approximately $84,000. Wells Fargo & Company MN boosted its position in shares of U.S. Physical Therapy by 2.2% during the 4th quarter. Wells Fargo & Company MN now owns 112,959 shares of the company’s stock valued at $10,021,000 after acquiring an additional 2,465 shares during the last quarter. Deutsche Bank AG boosted its position in shares of U.S. Physical Therapy by 49.3% during the 4th quarter. Deutsche Bank AG now owns 13,176 shares of the company’s stock valued at $1,169,000 after acquiring an additional 4,350 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of U.S. Physical Therapy by 35.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 35,761 shares of the company’s stock valued at $3,172,000 after acquiring an additional 9,395 shares during the last quarter.

Analysts Set New Price Targets

A number of brokerages recently issued reports on USPH. Barrington Research restated an “outperform” rating and issued a $98.00 price target on shares of U.S. Physical Therapy in a research report on Tuesday, July 1st. Wall Street Zen upgraded U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Thursday, May 8th. JPMorgan Chase & Co. lowered their price target on U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating for the company in a research report on Wednesday, March 19th. Finally, JMP Securities restated a “market outperform” rating and issued a $113.00 price target on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $109.00.

U.S. Physical Therapy Price Performance

Shares of NYSE USPH opened at $73.12 on Wednesday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.17 and a current ratio of 1.17. The company has a market cap of $1.11 billion, a PE ratio of 33.54, a P/E/G ratio of 3.58 and a beta of 1.44. The business has a 50-day simple moving average of $76.69 and a two-hundred day simple moving average of $78.76. U.S. Physical Therapy, Inc. has a fifty-two week low of $62.77 and a fifty-two week high of $101.20.

U.S. Physical Therapy (NYSE:USPH) last released its earnings results on Wednesday, May 7th. The company reported $0.48 EPS for the quarter, topping analysts’ consensus estimates of $0.46 by $0.02. U.S. Physical Therapy had a return on equity of 7.89% and a net margin of 4.57%. The firm had revenue of $183.79 million during the quarter, compared to the consensus estimate of $176.78 million. During the same quarter in the previous year, the company posted $0.51 earnings per share. The company’s revenue was up 18.0% compared to the same quarter last year. As a group, equities analysts expect that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, June 13th. Investors of record on Friday, May 23rd were given a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a yield of 2.46%. The ex-dividend date was Friday, May 23rd. U.S. Physical Therapy’s dividend payout ratio is currently 82.57%.

Insiders Place Their Bets

In other news, Director Nancy Ham sold 400 shares of the business’s stock in a transaction that occurred on Thursday, June 12th. The stock was sold at an average price of $78.01, for a total value of $31,204.00. Following the completion of the sale, the director directly owned 2,594 shares in the company, valued at $202,357.94. The trade was a 13.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 2.00% of the company’s stock.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.